Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liver cancer prognosis related serum miRNA markers and application of detection kit thereof

A liver cancer prognosis and kit technology, applied in the field of biomedicine, can solve the problems of short primer sequence, limited specificity and sensitivity, high cost, etc., and achieve the effect of high innovation significance and high clinical application value

Active Publication Date: 2016-06-08
SUN YAT SEN UNIV CANCER CENT
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The content in serum is far lower than that in tissues, requiring a very sensitive and specific detection method; and because the primer sequence is short, primer design is difficult, there is no targeted software that can be used directly, and there is no labeled internal reference gene as a reference, so Primers, reaction systems and internal reference systems all need to be screened and optimized
At present, high-throughput screening for miRNA generally uses chip technology, which has high cost, limited specificity and sensitivity, and cannot meet the needs of real-time detection of scattered samples.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liver cancer prognosis related serum miRNA markers and application of detection kit thereof
  • Liver cancer prognosis related serum miRNA markers and application of detection kit thereof
  • Liver cancer prognosis related serum miRNA markers and application of detection kit thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] 1. The composition of the kit

[0058] The liver cancer serum miRNA detection kit for assessing the risk of liver cancer prognosis in this embodiment includes reagents for preparing a reverse transcription reaction system, reagents for preparing a qPCR reaction system, and reagents for preparing an internal reference system.

[0059] 1. Internal reference system

[0060] The reagents used to prepare the internal reference system include the internal reference cel-miR-39 solution. The internal reference solution is the nematode cel-miR-39 solution (AccessionNumber: AJ487564), synthesized by Yingwei Jieji Shanghai Trading Co., Ltd., encapsulated in a vial, the prepared concentration is 20μM, a total of 10μl, the use concentration is 0.05pmol / μl, As shown in Table 1.

[0061] Table 1 Component list of internal reference system

[0062] components

volume

use concentration

cel-miR-39 solution

2μl

0.05pmol / μl

[0063] 2. Reverse tran...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The invention discloses liver cancer prognosis related serum miRNA markers and an application of a detection kit thereof. The tumor markers are serum miR-29a-3p and miR-192-5p which are related with human liver cancer patients. According to preliminary work, liver cancer related serum miRNA expression profiles containing miR-29a-3p and miR-192-5p and having obvious expression difference are screened out through high-throughput deep sequencing, and qPCR (quantitative polymerase chain reaction) proves and finally confirms that miR-29a-3p and miR-192-5p are liver cancer risk (prognosis) related tumor markers. The markers and detection reagents can be used for preparing the rapid-detection pPCR kit, and the kit has the characteristics of rapidness and convenience in detection, high accuracy rate, no wound and the like; a prognostic model built through combination of miR-29a-3p, miR-192-5p and BCLC stage (Barcelona clinic liver cancer stage) can be applied to classification of risk degrees of the liver cancer patients, thereby guiding individualized treatment of the liver cancer patients.

Description

technical field [0001] The invention belongs to the field of biomedicine, and specifically relates to a serum miRNA detection product and the application of miR-29a-3p and miR-192-5p as liver cancer risk (prognosis) tumor molecular markers. Background technique [0002] Liver cancer is the second most common malignant tumor in my country. Because it is a country with a large number of hepatitis B infections, there are many new patients every year, accounting for about 50% of the world's new patients. The existing TNM staging and alpha-fetoprotein (AFP) cannot guide the prognosis of patients well. Many early-stage patients are prone to recurrence and metastasis even after surgery. There is an urgent need for new molecular markers to guide the prognosis of patients and achieve risk classification and stratification. purpose to guide individualized treatment. [0003] Tumor markers (tumormarkers, TM) refer to those synthesized and secreted by the gene expression of tumor cells...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12Q1/68
CPCC12Q1/6886C12Q2600/158C12Q2600/178
Inventor 邵建永朱浩图
Owner SUN YAT SEN UNIV CANCER CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products